Global X Scientific Beta Europe ETF
SCID
New York Stock Exchange Arca- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Global X Scientific Beta Europe ETF (SCID) is an exchange-traded fund that seeks to provide investment results corresponding to the performance of the Scientific Beta Developed Europe Multi-Beta Multi-Strategy Index before fees and expenses. The fund employs a multi-factor investment strategy utilizing six proprietary risk and return factors developed by EDHEC-Risk Institute—low volatility, momentum, quality, value, investability, and size—to construct a diversified portfolio of European equities; it invests at least 80% of its total assets in securities that comprise the underlying index or depositary receipts representing such securities, with holdings rebalanced quarterly and screened for liquidity and investability criteria. SCID targets institutional and retail investors seeking enhanced risk-adjusted returns in the European developed markets, operating primarily in countries including the United Kingdom, France, Germany, Switzerland, and the Netherlands, and is issued by Global X Management Company LLC, a subsidiary of Mirae Asset Global Investments Co., Ltd., with the firm headquartered in New York, USA. Launched in 2015 as part of Global X's suite of smart beta ETFs, the fund remains domiciled in the United States and listed on major exchanges with no reported recent acquisitions, funding rounds, partnerships, or strategic shifts specific to SCID within the last two years.